YKL40as a therapeutic target for the treatment of metastatic Prostate Cancer

被引：0
|
作者：
Jeet, Varinder [1 ]
Nelson, Colleen Coyne [1 ]
机构：
[1] Queensland Univ Technol, Brisbane, Qld 4001, Australia
来源：
BJU INTERNATIONAL | 2013年 / 112卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：45 / 45
页数：1
相关论文
共 50 条
  • [21] MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer
    Nickols, Nicholas G.
    Nazarian, Ramin
    Zhao, Shuang G.
    Tan, Victor
    Uzunangelov, Vladislav
    Xia, Zheng
    Baertsch, Robert
    Neeman, Elad
    Gao, Allen C.
    Thomas, George, V
    Howard, Lauren
    De Hoedt, Amanda M.
    Stuart, Josh
    Goldstein, Theodore
    Chi, Kim
    Gleave, Martin E.
    Graff, Julie N.
    Beer, Tomasz M.
    Drake, Justin M.
    Evans, Christopher P.
    Aggarwal, Rahul
    Foye, Adam
    Feng, Felix Y.
    Small, Eric J.
    Aronson, William J.
    Freedland, Stephen J.
    Witte, Owen N.
    Huang, Jiaoti
    Alumkal, Joshi J.
    Reiter, Robert E.
    Retti, Matthew B.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2019, 22 (04) : 531 - 538
  • [22] Angiogenesis as Therapeutic Target in Metastatic Prostate Cancer - Narrowing the Gap Between Bench and Bedside
    Solimando, Antonio Giovanni
    Kalogirou, Charis
    Krebs, Markus
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [23] MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer
    Nicholas G. Nickols
    Ramin Nazarian
    Shuang G. Zhao
    Victor Tan
    Vladislav Uzunangelov
    Zheng Xia
    Robert Baertsch
    Elad Neeman
    Allen C. Gao
    George V. Thomas
    Lauren Howard
    Amanda M. De Hoedt
    Josh Stuart
    Theodore Goldstein
    Kim Chi
    Martin E. Gleave
    Julie N. Graff
    Tomasz M. Beer
    Justin M. Drake
    Christopher P. Evans
    Rahul Aggarwal
    Adam Foye
    Felix Y. Feng
    Eric J. Small
    William J. Aronson
    Stephen J. Freedland
    Owen N. Witte
    Jiaoti Huang
    Joshi J. Alumkal
    Robert E. Reiter
    Matthew B. Rettig
    Prostate Cancer and Prostatic Diseases, 2019, 22 : 531 - 538
  • [24] The role of clusterin in prostate cancer: treatment resistance and potential as a therapeutic target
    Muhammad, Lateef A.
    Saad, Fred
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (09) : 1049 - 1061
  • [25] Expression of osteocalcin by primary and metastatic prostate cancer and human prostate cell lines: A novel therapeutic target for prostate cancer metastasis.
    Ou, YC
    Gardner, TA
    Ko, SC
    Zhau, HYE
    Kao, CH
    Yeung, F
    Chung, LWK
    JOURNAL OF UROLOGY, 1998, 159 (05): : 2 - 2
  • [26] TREATMENT OF METASTATIC CANCER OF THE PROSTATE
    FOURNIER, G
    MANGIN, P
    PRESSE MEDICALE, 1995, 24 (32): : 1465 - &
  • [27] Treatment of metastatic prostate cancer
    Gilson, Clare
    Manickavasagar, Thubeena
    Chowdhury, Simon
    TRENDS IN UROLOGY & MENS HEALTH, 2015, 6 (04) : 7 - 12
  • [28] The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate Cancer
    Darr, Christopher
    Krafft, Ulrich
    Hadaschik, Boris
    Tschirdewahn, Stephan
    Sevcenco, Sabina
    Csizmarik, Anita
    Nyirady, Peter
    Kueronya, Zsofia
    Reis, Henning
    Maj-Hes, Agnieszka
    Shariat, Shahrokh F.
    Kramer, Gero
    Szarvas, Tibor
    UROLOGIA INTERNATIONALIS, 2018, 101 (01) : 65 - 73
  • [29] MALAT1: A Promising Therapeutic Target for the Treatment of Metastatic Colorectal Cancer
    Uthman, Yaaqub Abiodun
    Ibrahim, Kasimu Ghandi
    Abubakar, Bilyaminu
    Bello, Muhammad Bashir
    Malami, Ibrahim
    Imam, Mustapha Umar
    Qusty, Naeem
    Cruz-Martins, Natalia
    Batiha, Gaber El-Saber
    Abubakar, Murtala Bello
    BIOCHEMICAL PHARMACOLOGY, 2021, 190
  • [30] YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer's Disease
    Muszynski, Pawel
    Groblewska, Magdalena
    Kulczynska-Przybik, Agnieszka
    Kulakowska, Alina
    Mroczko, Barbara
    CURRENT NEUROPHARMACOLOGY, 2017, 15 (06) : 906 - 917
12345